Compile Data Set for Download or QSAR
Report error Found 295 Enz. Inhib. hit(s) with all data for entry = 7628
TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791488BDBM791488(US20260035382, Compound 186)
Affinity DataIC50: 16.3nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791485BDBM791485(US20260035382, Compound 183)
Affinity DataIC50: 18.7nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791425BDBM791425(US20260035382, Compound 117)
Affinity DataIC50: 19.1nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791497BDBM791497(US20260035382, Compound 195)
Affinity DataIC50: 21.3nMAssay Description:CHO cells were transfected with an expression vector encoding rat 5-HT7 gene and CRE-Luc reporter system. Colonies were isolated and screened with 10...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791422BDBM791422(US20260035382, Compound 114)
Affinity DataIC50: 22.8nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791478BDBM791478(US20260035382, Compound 176)
Affinity DataIC50: 23.2nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791491BDBM791491(US20260035382, Compound 189)
Affinity DataIC50: 24.5nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791494BDBM791494(US20260035382, Compound 192)
Affinity DataIC50: 25.1nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791503BDBM791503(US20260035382, Compound 201)
Affinity DataIC50: 26.5nMAssay Description:Detection of the effect of compounds on p-MEK1/2, t-ERK1/2, pERK1/2, p-Rsk1 and p-Elk-1 activity in B16-F10 cells was performed using ELISA kits (Inv...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791314BDBM791314(US20260035382, Compound 6)
Affinity DataIC50: 27.8nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791500BDBM791500(US20260035382, Compound 198)
Affinity DataIC50: 28.8nMAssay Description:Muscarinic acetylcholine receptor M1 was cloned into an expression vector and transfected in CHO cells along with CRE-Luc reporter system. Isolated c...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791401BDBM791401(US20260035382, Compound 93)
Affinity DataIC50: 28.9nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791317BDBM791317(US20260035382, Compound 9)
Affinity DataIC50: 36nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791356BDBM791356(US20260035382, Compound 48)
Affinity DataIC50: 41nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791467BDBM791467(US20260035382, Compound 159)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791464BDBM791464(US20260035382, Compound 156)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791462BDBM791462(US20260035382, Compound 154)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791335BDBM791335(US20260035382, Compound 27)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791461BDBM791461(US20260035382, Compound 153)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791545BDBM791545(US20260035382, Compound 243)
Affinity DataIC50: 50nMAssay Description:CHO cells stably expressing human TRPV1 (hTRPV1) were used. Functional assessment of heat-induced activation of hTRPV1 was carried out in a cell-base...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791344BDBM791344(US20260035382, Compound 36)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791345BDBM791345(US20260035382, Compound 37)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791483BDBM791483(US20260035382, Compound 181)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791480BDBM791480(US20260035382, Compound 178)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791350BDBM791350(US20260035382, Compound 42)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791489BDBM791489(US20260035382, Compound 187)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791486BDBM791486(US20260035382, Compound 184)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791495BDBM791495(US20260035382, Compound 193)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791492BDBM791492(US20260035382, Compound 190)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791566BDBM791566(US20260035382, Compound 264)
Affinity DataIC50: 50nMAssay Description:Inhibition of O-GlcNAcase, which removes O-GlcNAc from cellular proteins, results in an increase in the level of O-GlcNAcylated protein in cells. An ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791567BDBM791567(US20260035382, Compound 265)
Affinity DataIC50: 50nMAssay Description:Inhibition of O-GlcNAcase, which removes O-GlcNAc from cellular proteins, results in an increase in the level of O-GlcNAcylated protein in cells. An ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791377BDBM791377(US20260035382, Compound 69)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791563BDBM791563(US20260035382, Compound 261)
Affinity DataIC50: 50nMAssay Description:Inhibition of O-GlcNAcase, which removes O-GlcNAc from cellular proteins, results in an increase in the level of O-GlcNAcylated protein in cells. An ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791386BDBM791386(US20260035382, Compound 78)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791602BDBM791602(US20260035382, Compound 300)
Affinity DataIC50: 50nMAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791510BDBM791510(US20260035382, Compound 208)
Affinity DataIC50: 50nMAssay Description:Detection of the effect of compounds on p-MEK1/2, t-ERK1/2, pERK1/2, p-Rsk1 and p-Elk-1 activity in B16-F10 cells was performed using ELISA kits (Inv...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791511BDBM791511(US20260035382, Compound 209)
Affinity DataIC50: 50nMAssay Description:Detection of the effect of compounds on p-MEK1/2, t-ERK1/2, pERK1/2, p-Rsk1 and p-Elk-1 activity in B16-F10 cells was performed using ELISA kits (Inv...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791508BDBM791508(US20260035382, Compound 206)
Affinity DataIC50: 50nMAssay Description:Detection of the effect of compounds on p-MEK1/2, t-ERK1/2, pERK1/2, p-Rsk1 and p-Elk-1 activity in B16-F10 cells was performed using ELISA kits (Inv...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791392BDBM791392(US20260035382, Compound 84)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791509BDBM791509(US20260035382, Compound 207)
Affinity DataIC50: 50nMAssay Description:Detection of the effect of compounds on p-MEK1/2, t-ERK1/2, pERK1/2, p-Rsk1 and p-Elk-1 activity in B16-F10 cells was performed using ELISA kits (Inv...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791518BDBM791518(US20260035382, Compound 216)
Affinity DataIC50: 50nMAssay Description:Detection of the effect of compounds on p-MEK1/2, t-ERK1/2, pERK1/2, p-Rsk1 and p-Elk-1 activity in B16-F10 cells was performed using ELISA kits (Inv...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791554BDBM791554(US20260035382, Compound 252)
Affinity DataIC50: 50nMAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791519BDBM791519(US20260035382, Compound 217)
Affinity DataIC50: 50nMAssay Description:Detection of the effect of compounds on p-MEK1/2, t-ERK1/2, pERK1/2, p-Rsk1 and p-Elk-1 activity in B16-F10 cells was performed using ELISA kits (Inv...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791514BDBM791514(US20260035382, Compound 212)
Affinity DataIC50: 50nMAssay Description:Detection of the effect of compounds on p-MEK1/2, t-ERK1/2, pERK1/2, p-Rsk1 and p-Elk-1 activity in B16-F10 cells was performed using ELISA kits (Inv...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791398BDBM791398(US20260035382, Compound 90)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791515BDBM791515(US20260035382, Compound 213)
Affinity DataIC50: 50nMAssay Description:Detection of the effect of compounds on p-MEK1/2, t-ERK1/2, pERK1/2, p-Rsk1 and p-Elk-1 activity in B16-F10 cells was performed using ELISA kits (Inv...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791399BDBM791399(US20260035382, Compound 91)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791551BDBM791551(US20260035382, Compound 249)
Affinity DataIC50: 50nMAssay Description:To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791512BDBM791512(US20260035382, Compound 210)
Affinity DataIC50: 50nMAssay Description:Detection of the effect of compounds on p-MEK1/2, t-ERK1/2, pERK1/2, p-Rsk1 and p-Elk-1 activity in B16-F10 cells was performed using ELISA kits (Inv...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetSUMO-activating enzyme subunit 1/2(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 791396BDBM791396(US20260035382, Compound 88)
Affinity DataIC50: 50nMAssay Description:Compounds were tested on human Nav1.7 (hNav1.7) expressed stably in 293 cells, which have no endogenous sodium channels. Two forms of whole-cell patc...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

Displayed 1 to 50 (of 295 total ) | Next | Last >>
Jump to: